Findings presented at the SLEEP 2020 Virtual Annual Meeting suggest that taking longer, more frequent naps during the day may be associated with incident Alzheimer dementia risk among community-based older...
Findings from a phase 3 trial assessing the safety and efficacy of daridorexant among adult and elderly patients with insomnia were presented at SLEEP 2020.
The American Academy of Sleep Medicine has called for an end to daylight savings time in a new position statement, citing potential public health and safety benefits.
In a recent study, researchers investigated the effects of various trajectories of sleep problems in early and middle childhood on psychosocial and academic outcomes among older children.
The new drug is the first FDA-approved option for this indication in more than 15 years and contains significantly less sodium than a current standard-of-care option.
Members of the Association of Pulmonary, Critical Care, and Sleep Division Directors and the American Thoracic Society have developed guidance for safely resuming elective outpatient pulmonary and sleep...
Previous research has shown that poor sleep quality is associated with worsened asthma symptoms among adolescents. Now, new research reveals the impact of short and long sleep duration on the frequency of...
Can a combination of noradrenergic and antimuscarinic drugs improve the endotypic traits of patients with obstructive sleep apnea? Find out what the authors of a new study determined.
